Your browser doesn't support javascript.
loading
A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies.
Boddu, Prajwal C; Senapati, Jayastu; Ravandi-Kashani, Farhad; Jabbour, Elias J; Jain, Nitin; Ayres, Mary; Chen, Yuling; Keating, Michael J; Kantarjian, Hagop M; Gandhi, Varsha; Kadia, Tapan M.
Afiliação
  • Boddu PC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Senapati J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ravandi-Kashani F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jabbour EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ayres M; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Chen Y; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Keating MJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Gandhi V; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kadia TM; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Cancer ; 129(4): 580-589, 2023 02 15.
Article em En | MEDLINE | ID: mdl-36448227

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Leucemia-Linfoma Linfoblástico de Células Precursoras / Leucemia-Linfoma Linfoblástico de Células T Precursoras Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Leucemia-Linfoma Linfoblástico de Células Precursoras / Leucemia-Linfoma Linfoblástico de Células T Precursoras Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article